Show simple item record

dc.contributor.authorKiburg, KV
dc.contributor.authorWard, GM
dc.contributor.authorO'Neal, DN
dc.contributor.authorMacIsaac, RJ
dc.date.accessioned2021-09-17T02:59:05Z
dc.date.available2021-09-17T02:59:05Z
dc.date.issued2018-02-01
dc.identifier.citationKiburg, K. V., Ward, G. M., O'Neal, D. N. & MacIsaac, R. J. (2018). Lipid-lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic. INTERNAL MEDICINE JOURNAL, 48 (2), pp.201-204. https://doi.org/10.1111/imj.13691.
dc.identifier.issn1444-0903
dc.identifier.urihttp://hdl.handle.net/11343/283574
dc.description.abstractWe documented temporal changes in the use of lipid-lowering medications and achievement of cholesterol targets in an Australian diabetes clinic. The number of patients using lipid-lowering therapy for primary or secondary cardiovascular prevention increased from 6 to 69% between 1993-1995 and 2014-2016, which corresponded to a decrease in low-density lipoprotein cholesterol levels from 3.7 to 2.4 mmol/L (P < 0.01).
dc.languageEnglish
dc.publisherWILEY
dc.titleLipid-lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic
dc.typeJournal Article
dc.identifier.doi10.1111/imj.13691
melbourne.affiliation.departmentCentre for Eye Research Australia (CERA)
melbourne.affiliation.departmentMedical Education
melbourne.affiliation.departmentMedicine (St Vincent's)
melbourne.affiliation.facultyAffiliate
melbourne.affiliation.facultyMedicine, Dentistry & Health Sciences
melbourne.source.titleInternal Medicine Journal
melbourne.source.volume48
melbourne.source.issue2
melbourne.source.pages201-204
melbourne.elementsid1305561
melbourne.contributor.authorMacIsaac, Richard
melbourne.contributor.authorO'Neal, David
melbourne.contributor.authorWard, Glenn
melbourne.contributor.authorKiburg, Katerina
dc.identifier.eissn1445-5994
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record